Table 2 Multivariate analysis relating clinico-pathologic features to likelihood of scattered pattern of residual tumor.

From: Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer

 

OR

95% CI

p value

Tumor size (per mm)

1.022

1.005–1.040

0.013

Nodal status

 Negative

1 (ref)

  

 Positive

1.135

0.655–1.967

0.651

Focality

 Unifocal

1 (ref)

  

 Multifocal

2.742

0.984–7.644

0.05

 Multicentric

0.975

0.527–1.804

0.94

Histologic grade

 3

1 (ref)

  

 1 or 2

2.894

1.468–5.704

0.002

Tumor subtype

 Triple-negative

1 (ref)

  

 HR−/HER2+

1.344

0.563–3.211

0.505

 HR+/HER2+

3.275

1.589–6.750

0.001

 HR+/HER2−

6.673

3.374–13.197

<0.001

  1. OR odds ratio, CI confidence interval, HR hormone receptor.
Back to article page